Chitosan-based nanoparticles for tumor-targeted drug delivery

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Nanoparticles (NPs) are promising for cancer therapy, overcoming conventional treatment limitations.
• Chitosan-based NPs offer biodegradability, biocompatibility, and enhanced drug delivery capabilities.
• These NPs improve drug properties through controlled release and targeted delivery.

Purpose of the Study:

• To review recent advancements in chitosan-based nanoparticles for cancer therapy.
• To discuss the preparation and properties of these nanoparticles.
• To highlight their tumor-targeted drug delivery applications.

Main Methods:

• Review of current literature on chitosan-based nanoparticles.
• Analysis of NP preparation techniques and characterization.
• Evaluation of in vitro and in vivo studies on drug delivery and targeting.

Main Results:

• Chitosan NPs demonstrate excellent biocompatibility, biodegradability, and drug loading capacity.
• Their unique properties enable pH-dependent drug release and prolonged circulation.
• Demonstrated potential for enhanced chemotherapy and cancer diagnosis.

Conclusions:

• Chitosan-based nanoparticles are highly effective drug delivery systems for cancer.
• Their tunable properties facilitate targeted delivery and improved therapeutic outcomes.
• Further research into chitosan NPs promises significant advancements in oncology.